Pages that link to "Q38100438"

The following pages link to How genetic modifiers influence the phenotype of spinal muscular atrophy and suggest future therapeutic approaches (Q38100438):

Displaying 37 items.

• Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases (Q26750803) (← links)
• Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative Diseases (Q26799331) (← links)
• Spinal Muscular Atrophy: From Defective Chaperoning of snRNP Assembly to Neuromuscular Dysfunction (Q33775770) (← links)
• Prevalence, incidence and carrier frequency of 5q-linked spinal muscular atrophy - a literature review. (Q33869164) (← links)
• Assays for the identification and prioritization of drug candidates for spinal muscular atrophy (Q34082155) (← links)
• SMN regulates axonal local translation via miR-183/mTOR pathway (Q34736851) (← links)
• Disease mechanisms and therapeutic approaches in spinal muscular atrophy (Q35707832) (← links)
• Biomarker for Spinal Muscular Atrophy: Expression of SMN in Peripheral Blood of SMA Patients and Healthy Controls (Q35808086) (← links)
• An Integrative Transcriptomic Analysis for Identifying Novel Target Genes Corresponding to Severity Spectrum in Spinal Muscular Atrophy (Q36058683) (← links)
• A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls (Q36205773) (← links)
• The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype (Q37231423) (← links)
• Splicing factor TRA2B is required for neural progenitor survival (Q37374977) (← links)
• The role of miRNA in motor neuron disease. (Q38187648) (← links)
• Invited review: decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art. (Q38260614) (← links)
• Investigational therapies for the treatment of spinal muscular atrophy. (Q38441280) (← links)
• Spinal muscular atrophy--recent therapeutic advances for an old challenge. (Q38489298) (← links)
• Advances in understanding the role of disease-associated proteins in spinal muscular atrophy. (Q38668630) (← links)
• Neurocalcin Delta Suppression Protects against Spinal Muscular Atrophy in Humans and across Species by Restoring Impaired Endocytosis (Q38718928) (← links)
• Translational development of splice-modifying antisense oligomers (Q38996657) (← links)
• Plastin 3 is upregulated in iPSC-derived motoneurons from asymptomatic SMN1-deleted individuals. (Q41119982) (← links)
• Analysis and annotation of whole-genome or whole-exome sequencing-derived variants for clinical diagnosis (Q43590500) (← links)
• Moving towards treatments for spinal muscular atrophy: hopes and limits (Q45875383) (← links)
• Analysis and Annotation of Whole-Genome or Whole-Exome Sequencing Derived Variants for Clinical Diagnosis (Q47770082) (← links)
• Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice (Q58762112) (← links)
• Use of ivacaftor in late diagnosed cystic fibrosis monozygotic twins heterozygous for F508del and R117H-7T - a case report (Q64053802) (← links)
• Nerve sprouting capacity in a pharmacologically induced mouse model of spinal muscular atrophy. (Q64997231) (← links)
• Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients (Q86012279) (← links)
• Nusinersen treatment and cerebrospinal fluid neurofilaments: An explorative study on Spinal Muscular Atrophy type 3 patients (Q89595212) (← links)
• Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden? (Q90124758) (← links)
• Prospective and longitudinal natural history study of patients with Type 2 and 3 spinal muscular atrophy: Baseline data NatHis-SMA study (Q90499492) (← links)
• One Year of Newborn Screening for SMA - Results of a German Pilot Project (Q90593635) (← links)
• Molecular Factors Involved in Spinal Muscular Atrophy Pathways as Possible Disease-modifying Candidates (Q90674893) (← links)
• ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy (Q91901763) (← links)
• The frequency of SMN gene variants lacking exon 7 and 8 is highly population dependent (Q92146942) (← links)
• NCALD Antisense Oligonucleotide Therapy in Addition to Nusinersen further Ameliorates Spinal Muscular Atrophy in Mice (Q92967239) (← links)
• Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients (Q93006923) (← links)
• Molecular diagnosis and genetic counseling for spinal muscular atrophy (SMA) (Q104567667) (← links)